Neutropenia and infections: Neutrophil replacement through genetic engineering
- PMID: 35362111
- DOI: 10.1002/JLB.1CE0122-031R
Neutropenia and infections: Neutrophil replacement through genetic engineering
Comment on
-
Transfusable neutrophil progenitors as cellular therapy for the prevention of invasive fungal infections.J Leukoc Biol. 2022 Jun;111(6):1133-1145. doi: 10.1002/JLB.4HI1221-722R. Epub 2022 Mar 31. J Leukoc Biol. 2022. PMID: 35355310 Free PMC article.
References
REFERENCES
-
- Sykes et al. (JLB to complete reference)
-
- Cartwright GE, Athens JW, Wintrobe MM. The kinetics of granulopoeisis in normal man. Blood. 1964; 24: 780-803.
-
- Freireich EJ, Levin RH, Whang J, Carbone PP, Bronson W, Morse EE. The function and fate of transfused leukocytes from donors with chronic myelocytic leukemia in leukopenic recipients. Ann NY Acad Sci. 1964; 113: 1081-1089.
-
- Dale DC, Reynolds HY, Pennington JE, Elin RJ, Pitts TW, Graw RG. Granulocyte transfusion therapy of experimental Pseudomonas pneumonia. J Clin Invest. 1974; 54: 664-671.
-
- Dale DC, Liles WC, Llewellyn C, Rodger E, Price TH. Neutrophil transfusions: kinetics and functions of neutrophils mobilized with granulocyte colony-stimulating factor (G-CSF) and dexamethasone. Transfusion. 1998; 38: 713-721.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
